GS1 Healthcare -- Improving patient safety worldwide
21st Global GS1 Healthcare Conference
Sydney, 20-22 March 2012
When Supply Chain meets eHealth -
the importance of laying the foundations in Healthcare
Raising the bar on patient safety and supply chain efficiency
Join a few hundred key stakeholders at the 21st Global GS1 Healthcare Conference in
Sydney from 20 to 22 March 2012.
Participants from around the world join the global GS1 Healthcare conferences to:
- gather the latest on industry and regulatory developments in automatic
identification, traceability and electronic product catalogues
- leverage a unique neutral and international platform to network and benchmark
with other stakeholders from around the world
- learn more about existing supply chain data standards
Successfully Bringing Together Supply Chain Stakeholders
The Global GS1 Healthcare Conference brings together all related Healthcare supply
chain stakeholders to advance the development and adoption of global standards in the
Healthcare supply chain. Key stakeholders in the Healthcare supply chain are invited to
participate in the global GS1 Healthcare Conference, including representatives from
(inter-)governmental bodies and regulators, Healthcare providers, pharmacists,
manufacturers, distributors & wholesalers, logistics providers, industry associations, and
GS1 Member Organisations representing local communities.
GS1 Australia - Healthcare Industry:
The Healthcare industry sector in Australia is a major part of the economy with total public and private expenditure on Healthcare equaling approximately 10% of GDP and with more than 65,000 million dollars spent on Healthcare per annum.
Healthcare is a complex industry sector where patient safety is paramount but where other drivers; such as the ability to authenticate pharmaceuticals and medical devices, track and trace products from manufacture to the patient, and supply chain improvement - come a close second.
There are more than 1200 public and private sector hospitals in Australia. The majority of doctors, including GPs, are self-employed with a small proportion consisting of salaried employees of Commonwealth, State or Local Governments.
The import and supply of medicines and medical devices is regulated by the Australian Therapeutic Goods Administration (TGA) in order to ensure the quality, safety and effectiveness of the products.
Medicines, or pharmaceuticals, prescribed by doctors and dispensed in the community by independent private sector pharmacies are directly subsidised by the Commonwealth Pharmaceutical Benefits Scheme (PBS).